
23 Feb Biogen
Junghae Suh, Ph.D., VP, Head of Gene Therapy Accelerator Unit
Cambridge, MA
(NASDAQ: BIIB)
Virtual Presentation
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.